2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
…, P Mease, HA Ménard, LW Moreland… - Arthritis & …, 2010 - Wiley Online Library
Objective The 1987 American College of Rheumatology (ACR; formerly, the American
Rheumatism Association) classification criteria for rheumatoid arthritis (RA) have been criticized …
Rheumatism Association) classification criteria for rheumatoid arthritis (RA) have been criticized …
Genetics of rheumatoid arthritis contributes to biology and drug discovery
…, S Eyre, J Bowes, A Barton, N De Vries, LW Moreland… - Nature, 2014 - nature.com
A major challenge in human genetics is to devise a systematic strategy to integrate disease-associated
variants with diverse genomic and biological data sets to provide insight into …
variants with diverse genomic and biological data sets to provide insight into …
[HTML][HTML] A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
…, MC Genovese, MC Wasko, LW Moreland… - … England Journal of …, 2000 - Mass Medical Soc
Background Etanercept, which blocks the action of tumor necrosis factor, reduces disease
activity in patients with long-standing rheumatoid arthritis. Its efficacy in reducing disease …
activity in patients with long-standing rheumatoid arthritis. Its efficacy in reducing disease …
[HTML][HTML] Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)–Fc fusion protein
LW Moreland, SW Baumgartner… - … England Journal of …, 1997 - Mass Medical Soc
Background Tumor necrosis factor (TNF) is a proinflammatory cytokine involved in the
pathogenesis of rheumatoid arthritis, and antagonism of TNF may reduce the activity of the disease…
pathogenesis of rheumatoid arthritis, and antagonism of TNF may reduce the activity of the disease…
Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the …
…, EC Keystone, DE Furst, LW Moreland… - Arthritis & …, 2003 - Wiley Online Library
Objective To evaluate the efficacy and safety of adalimumab (D2E7), a fully human monoclonal
tumor necrosis factor α antibody, in combination with methotrexate (MTX) in patients with …
tumor necrosis factor α antibody, in combination with methotrexate (MTX) in patients with …
[PDF][PDF] 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the …
…, AF Kavanaugh, JM Kremer, LW Moreland… - Arthritis care & …, 2012 - Wiley Online Library
The American College of Rheumatology (ACR) most recently published recommendations
for the use of diseasemodifying antirheumatic drugs (DMARDs) and biologic agents in the …
for the use of diseasemodifying antirheumatic drugs (DMARDs) and biologic agents in the …
[HTML][HTML] Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis
…, NE Lane, JJ Cush, LW Moreland… - … England Journal of …, 2006 - Mass Medical Soc
Background Glucosamine and chondroitin sulfate are used to treat osteoarthritis. The
multicenter, double-blind, placebo- and celecoxib-controlled Glucosamine/chondroitin Arthritis …
multicenter, double-blind, placebo- and celecoxib-controlled Glucosamine/chondroitin Arthritis …
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis
…, C Maclean, T Mikuls, LW Moreland… - Arthritis Care & …, 2008 - Wiley Online Library
Guidelines and recommendations developed and/or endorsed by the American College of
Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and …
Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and …
Etanercept therapy in rheumatoid arthritis: a randomized, controlled trial
LW Moreland, MH Schiff, SW Baumgartner… - Annals of internal …, 1999 - acpjournals.org
Background: In a phase II study, etanercept (recombinant human tumor necrosis factor
receptor [p75]:Fc fusion protein) safely produced rapid, dose-dependent improvement in …
receptor [p75]:Fc fusion protein) safely produced rapid, dose-dependent improvement in …
Etanercept versus methotrexate in patients with early rheumatoid arthritis: two‐year radiographic and clinical outcomes
…, EC Keystone, MC Wasko, LW Moreland… - … : Official Journal of …, 2002 - Wiley Online Library
Objective To compare the clinical and radiographic outcomes in patients with rheumatoid
arthritis (RA) who received monotherapy with either etanercept or methotrexate (MTX) for 2 …
arthritis (RA) who received monotherapy with either etanercept or methotrexate (MTX) for 2 …